Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
24.08
-0.72 (-2.90%)
At close: Mar 6, 2026, 4:00 PM EST
24.85
+0.77 (3.20%)
After-hours: Mar 6, 2026, 6:50 PM EST
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.78 billion as of March 6, 2026. Its market cap has increased by 83.90% in one year.
Market Cap
1.78B
Enterprise Value
1.52B
1-Year Change
83.90%
Ranking
Category
Stock Price
$24.08
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.78B, an increase of 439.13%. That is a compound annual growth rate of 20.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.78B | -9.87% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.90B |
| Iovance Biotherapeutics | 1.89B |
| Recursion Pharmaceuticals | 1.87B |
| Tyra Biosciences | 1.86B |
| Veradermics | 1.82B |
| Palvella Therapeutics | 1.81B |
| Olema Pharmaceuticals | 1.77B |
| Enliven Therapeutics | 1.75B |